Survivin is expressed in early hepatocellular carcinoma and surrounding hepatitis tissue
Satoshi Mamori1, Masato Matsushima, Tomokazu Matsuura
1Division of Gastroenterology and Hepatology, Department of Internal Medicine, Daisan Hospital, The Jikei University School of Medicine, Tokyo 201-8601, Japan. mamori@jikei.ac.jp.
Abstract:
It has been suggested that survivin, a member of the inhibitor of apoptosis protein (IAP) family, is an attractive novel target for anticancer therapy. The present study investigated the expression of survivin during the early stages of hepatocellular carcinoma (HCC) and associated hepatitis, and attempted to elucidate how this expression is correlated with clinicopathological factors. Twenty-two patients (15 men and 7 women) underwent a liver tissue biopsy for the diagnosis of HCC. In the HCC and surrounding hepatitis-infected tissues, the average survivin expression rate was 62.36 and 31.41% (median), respectively. The serum level of ALT was correlated with the survivin expression rate in the HCC (r=-0.60, P<0.01) and hepatitis specimens (r=-0.43, P<0.05). The data suggest that certain clinicopathological factors may in future serve as useful indicators for the selection of patients responsive to the inhibition of survivin.
More Related Videos
06:38An Oncogenic Hepatocyte-Induced Orthotopic Mouse Model of Hepatocellular Cancer Arising in the Setting of Hepatic Inflammation and Fibrosis
Published on: September 12, 2019
12:24A Three-Dimensional Spheroid Model to Investigate the Tumor-Stromal Interaction in Hepatocellular Carcinoma
Published on: September 30, 2021
Related Concept Videos
Liver Regeneration
Cells of Liver
The liver comprises four major types of cells— hepatocytes, stellate, Kupffer, and sinusoidal endothelial cells. The hepatocytes are large...
Hepatitis
Liver Histology
Hepatocytes perform a variety of essential functions. They secrete...
Cirrhosis II: Pathophysiology
Viral Hepatitis I: Introduction
Cell Specific Gene Expression
